학술논문
Phase I Study of SYNB1891, an Engineered E. coli Nissle Strain Expressing STING Agonist, with and without Atezolizumab in Advanced Malignancies
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
15573265